» Articles » PMID: 8328774

Experimental Study of Transplacental Passage of Alpha Interferon by Two Assay Techniques

Overview
Specialty Pharmacology
Date 1993 Jun 1
PMID 8328774
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Two methods of assaying alpha interferon (IFN-alpha) were compared during an experiment aimed at determining whether IFN-alpha crosses the human placenta. Human placentas, collected after delivery following a normal pregnancy to term, were catheterized on both sides: fetal and maternal. The IFN-alpha was introduced in known amounts in the maternal circulation and was assayed in the efferent fetal fluid. The following two detection methods were used: radioimmunoassay by competition with [125I]IFN-alpha and assay with a biological system in which IFN-alpha protected Madin-Darby bovine kidney cells from destruction by vesicular stomatitis virus. The results obtained by the two methods were in perfect agreement for the efferent fetal fluid samples. They showed the absence of placental transfer of IFN-alpha. The biological method was found to be more sensitive than radioimmunoassay for low IFN-alpha titers (< 10 IU/ml) but was less reproducible, probably owing to the use of twofold dilutions. The specificities of the two methods were similar and their practicalities were equivalent; the biological method, however, was less costly. The study illustrates the complementarity of the two methods, which were based on different principles. The agreement obtained between the two methods provides a clear confirmation of the experimental results.

Citing Articles

Childbirth rates in women with myeloproliferative neoplasms.

Landtblom A, Andersson T, Johansson A, Lundberg F, Samuelsson J, Bjorkholm M Leukemia. 2024; 38(5):1081-1085.

PMID: 38461191 PMC: 11073981. DOI: 10.1038/s41375-024-02216-8.


Impacts of maternal microbiota and microbial metabolites on fetal intestine, brain, and placenta.

Husso A, Pessa-Morikawa T, Koistinen V, Karkkainen O, Kwon H, Lahti L BMC Biol. 2023; 21(1):207.

PMID: 37794486 PMC: 10552303. DOI: 10.1186/s12915-023-01709-9.


Transmitted Fetal Immune Response in Cases of SARS-CoV-2 Infections during Pregnancy.

Gonzalez-Mesa E, Garcia-Fuentes E, Carvia-Pontiasec R, Lavado-Fernandez A, Cuenca-Marin C, Suarez-Arana M Diagnostics (Basel). 2022; 12(2).

PMID: 35204335 PMC: 8870756. DOI: 10.3390/diagnostics12020245.


Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.

Louchet M, Sibiude J, Peytavin G, Picone O, Treluyer J, Mandelbrot L Am J Obstet Gynecol MFM. 2020; 2(3):100159.

PMID: 32838264 PMC: 7308040. DOI: 10.1016/j.ajogmf.2020.100159.


Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia.

Wedenoja S, Yoshihara M, Teder H, Sariola H, Gissler M, Katayama S EBioMedicine. 2020; 59:102872.

PMID: 32680723 PMC: 7502669. DOI: 10.1016/j.ebiom.2020.102872.


References
1.
Johnson V, Barlow M, Merrill D, Chou T, Hirsch M . Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A. J Infect Dis. 1990; 161(6):1059-67. DOI: 10.1093/infdis/161.6.1059. View

2.
Giroux M, Campistron G, Faure F, Dumas J, Coulais Y, Desprats R . Effects of pH on antipyrine transfer across the human placenta ex vivo. Dev Pharmacol Ther. 1990; 14(3):153-60. View

3.
Unadkat J, Schumann L, Smith A . Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J Acquir Immune Defic Syndr (1988). 1990; 3(10):959-64. View

4.
LHaridon R . Immunosorbent binding bioassay: a solid phase biological immunoassay for the titration of antisera to alpha interferons. J Immunoassay. 1991; 12(1):99-112. DOI: 10.1080/01971529108055059. View

5.
Newell M, Peckham C, Lepage P . HIV-1 infection in pregnancy: implications for women and children. AIDS. 1990; 4 Suppl 1:S111-7. View